• 1. An atomistic mechanism for the degradation of perovskite solar cells by trapped charge?
  Eunhak Lim,Jiyoung Heo,Seong Keun Kim Nanoscale, 2019,11, 11369-11378
• 2. An approach to C–N activation: coupling of arenesulfonyl hydrazides and arenesulfonyl chlorides with tert-amines via a metal-, oxidant- and halogen-free anodic oxidation??
  M. Sheykhan,S. Khani,S. Shaabanzadeh,M. Joafshan Green Chem., 2017,19, 5940-5948
• 3. Acentric and chiral heterometallic inorganic–organic hybrid frameworks mediated by alkali or alkaline earth ions: synthesis and NLO properties
  Huabin Zhang,Shaowu Du CrystEngComm, 2014,16, 4059-4068
• 4. An amorphous carbon nitride/NiO/CoN-based composite: a highly efficient nonprecious electrode for supercapacitors and the oxygen evolution reaction?
  Huifang Yang,Haoran Guo,Peidong Fan,Xinpan Li,Wenlu Ren,Rui Song Nanoscale, 2020,12, 7024-7034
• 5. Aluminium alkyl and aryloxide complexes of pyrazine and bipyridines: synthesis and structure?
  Doug Ogrin,Laura H. van Poppel,Simon G. Bott,Andrew R. Barron Dalton Trans., 2004, 3689-3694

3-Chloro-4-Iodo-1H-Pyrrolo[2,3-b]Pyridine: A Comprehensive Overview

3-Chloro-4-Iodo-1H-Pyrrolo[2,3-b]Pyridine, also known as CAS No. 1190313-54-2, is a highly specialized organic compound that has garnered significant attention in the fields of medicinal chemistry and materials science. This compound belongs to the class of pyrrolopyridines, which are heterocyclic structures combining pyrrole and pyridine rings. The presence of chlorine and iodine substituents at the 3 and 4 positions, respectively, imparts unique electronic and structural properties to this molecule.

The synthesis of 3-chloro-4-iodo-1H-pyrrolo[2,3-b]pyridine typically involves multi-step organic reactions, often utilizing palladium-catalyzed cross-coupling techniques. Recent advancements in catalytic methods have enabled the efficient construction of such complex heterocycles with high yields and purity. Researchers have explored various precursor molecules, including substituted pyrroles and pyridines, to optimize the synthesis pathway for this compound.

One of the most promising applications of 3-chloro-4-iodo-1H-pyrrolo[2,3-b]pyridine lies in its potential as a building block for drug discovery. Its rigid structure and ability to form hydrogen bonds make it an ideal candidate for targeting specific protein-protein interactions (PPIs). Recent studies have demonstrated its effectiveness in inhibiting certain oncogenic pathways, suggesting its potential as an anti-cancer agent. Additionally, the compound's electronic properties make it a strong candidate for use in optoelectronic materials, such as organic light-emitting diodes (OLEDs) and photovoltaic devices.

The structural uniqueness of 3-chloro-4-iodo-1H-pyrrolo[2,3-b]pyridine has also led to its investigation in the field of supramolecular chemistry. Researchers have explored its ability to form self-assembled structures through non-covalent interactions, which could have applications in nanotechnology and molecular recognition systems. Furthermore, its iodine substituent allows for potential radiotherapeutic applications, as iodine can be isotopically labeled for imaging and treatment purposes.

In terms of pharmacokinetics, studies have shown that 3-chloro-4-iodo-1H-pyrrolo[2,3-b]pyridine exhibits favorable absorption profiles in preclinical models. Its lipophilic nature enhances its ability to cross biological membranes, while its metabolic stability ensures sustained activity within the body. These properties make it a compelling candidate for further preclinical development.

The development of CAS No. 1190313-54-2 has been supported by cutting-edge analytical techniques such as X-ray crystallography and nuclear magnetic resonance (NMR) spectroscopy. These methods have provided detailed insights into the compound's three-dimensional structure and dynamic behavior in solution. Computational modeling has also played a crucial role in predicting the compound's interactions with biological targets and optimizing its pharmacological properties.

In conclusion, 3-chloro-4-iodo-1H-pyrrolo[2,3-b]pyridine, or CAS No. 1190313-54-2, represents a significant advancement in heterocyclic chemistry with diverse applications across multiple scientific domains. Its unique structure and functional groups continue to inspire innovative research directions, positioning it as a key molecule in the development of novel therapeutic agents and advanced materials.

• 2098070-20-1(2-(3-(Pyridin-3-yl)-1H-pyrazol-1-yl)acetimidamide)
• 2680771-01-9(4-cyclopentyl-3-{(prop-2-en-1-yloxy)carbonylamino}butanoic acid)
• 1444113-98-7(N-(3-cyanothiolan-3-yl)-2-[(2,2,2-trifluoroethyl)sulfanyl]pyridine-4-carboxamide)
• 332062-08-5(Fmoc-S-3-amino-4,4-diphenyl-butyric acid)
• 1270529-38-8(1,2,3,4,5,6-Hexahydro-[2,3]bipyridinyl-6-ol)
• 941977-17-9(N'-(3-chloro-2-methylphenyl)-N-2-(dimethylamino)-2-(naphthalen-1-yl)ethylethanediamide)
• 2138166-62-6(2,2-Difluoro-3-[methyl(2-methylbutyl)amino]propanoic acid)
• 89640-58-4(2-Iodo-4-nitrophenylhydrazine)
• 1449132-38-0(3-Fluoro-5-(2-fluoro-5-methylbenzylcarbamoyl)benzeneboronic acid)
• 2034271-14-0(2-(1H-indol-3-yl)-N-{[6-(thiophen-2-yl)-[1,2,4]triazolo[4,3-b]pyridazin-3-yl]methyl}acetamide)